What is FOLIX?

FOLIX (55 mL) is a prescription-strength topical solution formulated for the management of male pattern hair loss (androgenetic alopecia). It is designed for patients who require both follicular stimulation and localized androgen control with improved scalp tolerability.

Safety & Tolerability

• For external use only

• For adult males only

• Avoid contact with eyes

• Discontinue use if significant irritation occurs

• Not to be used by women who are pregnant or may become pregnant

Clinical Oversight & Compounding

Treatment protocols are determined following clinical evaluation and, where indicated, trichoscopic assessment.
The low-PG vehicle is selected to reduce dryness, irritation, and contact dermatitis commonly associated with standard formulations.

Compounded by: Healer Pharma

Actives %

Minoxidil 5% (Topical Hair Growth Agent)
Stimulates hair follicles and prolongs the anagen phase, supporting visible improvement in hair density with consistent use.

Finasteride 0.25% (Topical Androgen Modulator)
Acts locally at the scalp to reduce DHT activity, targeting androgen-mediated follicular miniaturization while minimizing systemic exposure.

Niacinamide 2% (Scalp Barrier & Tolerance Support)
Improves scalp barrier function, reduces irritation, and enhances long-term treatment compliance.

Why this

• Addresses the primary mechanisms of androgenetic alopecia
• Designed for improved scalp tolerance (low PG)
• Suitable for long‑term use under supervision
• Selection guided by clinical evaluation and trichoscopy

Formulated for consistency, not hype.

Ideal for

Indicated for:

• Adult males with androgenetic alopecia
• Crown, vertex, or diffuse thinning
• Early to moderate stages based on clinical assessment

Not indicated for:

• Women
• Scarring alopecias
• Acute inflammatory scalp disorders

How to Use

• Apply 1.75 mL once daily to a dry scalp

• Approx. 6–8 sprays

• Spread gently over affected areas

• Allow to dry completely

• Do not wash scalp for at least 4 hours

Results Timeline

• Weeks 4–8: Possible initial shedding
• Months 3–4: Reduction in hair fall
• Months 5–6: Visible improvement in density

Individual response may vary.